Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a model to understand heart aging, highlighting key genes and pathways, and suggesting miR-208a as a potential heart attack biomarker.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Minoxidil can reduce functions related to androgen receptors.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Environmental factors and chemicals might affect hormone balance and contribute to common hair loss.

AA–TF#15 significantly promotes hair regrowth and could be an effective treatment for androgenic alopecia.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

New understanding and treatments for hair loss are improving, but more research is needed.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Understanding how acne develops in different diseases could lead to new treatments.

Probiotics help reduce hair loss and increase hair growth in people with androgenic alopecia.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Caizhixuan hair tonic helps treat hair loss by promoting hair growth and improving hair follicles.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Men with androgenetic alopecia have oilier and less hydrated scalps, especially in sensitive areas.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Taohong Siwu Decoction may help treat hair loss by targeting multiple genes and pathways.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Supplemented Erzhi Wan may help regrow hair in male pattern baldness by affecting certain cell signaling pathways.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.